Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHAMS IQBAL

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1598846834
CMS profile
345071
Location
RIVERSIDE, CA

General Payments · PY2019–2024

$1,901.87

  • Reported across 77 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$931.29

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $931.29 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $63.39 2
PY2020 $62.17 2
PY2021 $36.91 2
PY2022 $188.34 8
PY2023 $619.77 25
PY2024 $931.29 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $24.81 01/16/2024 Food and Beverage Undisputed 01/23/2026 1105660364 CMS
AstraZeneca Pharmaceuticals LP $21.59 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105517095 CMS
AstraZeneca Pharmaceuticals LP $29.20 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105836929 CMS
AstraZeneca Pharmaceuticals LP $21.74 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105876759 CMS
AstraZeneca Pharmaceuticals LP $21.13 05/22/2024 Food and Beverage Undisputed 01/23/2026 1104565430 CMS
AstraZeneca Pharmaceuticals LP $18.86 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105885075 CMS
AstraZeneca Pharmaceuticals LP $15.21 10/10/2024 Food and Beverage Undisputed 01/23/2026 1104532834 CMS
AstraZeneca Pharmaceuticals LP $17.35 11/27/2024 Food and Beverage Undisputed 01/23/2026 1105628344 CMS
AstraZeneca Pharmaceuticals LP $27.77 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105866554 CMS
BioCryst US Sales Co., LLC $29.32 01/19/2024 Food and Beverage Undisputed 01/23/2026 1117476156 CMS
BioCryst US Sales Co., LLC $30.96 07/10/2024 Food and Beverage Undisputed 01/23/2026 1117475346 CMS
BioCryst US Sales Co., LLC $41.38 09/12/2024 Food and Beverage Undisputed 01/23/2026 1117478634 CMS
CSL Behring $31.39 02/01/2024 Food and Beverage Undisputed 01/23/2026 1134607963 CMS
CSL Behring $32.51 02/08/2024 Food and Beverage Undisputed 01/23/2026 1134607967 CMS
CSL Behring $1.75 03/06/2024 Food and Beverage Undisputed 01/23/2026 1134607971 CMS
CSL Behring $21.47 03/06/2024 Food and Beverage Undisputed 01/23/2026 1134607973 CMS
CSL Behring $28.70 07/12/2024 Food and Beverage Undisputed 01/23/2026 1134607995 CMS
CSL Behring $19.26 10/30/2024 Food and Beverage Undisputed 01/23/2026 1134608023 CMS
Genentech USA, Inc. $17.53 03/21/2024 Food and Beverage Undisputed 01/23/2026 1133110979 CMS
Genentech USA, Inc. $21.15 10/24/2024 Food and Beverage Undisputed 01/23/2026 1133110975 CMS
GENZYME CORPORATION $34.72 07/03/2024 Food and Beverage Undisputed 01/23/2026 1139673241 CMS
GlaxoSmithKline, LLC. $24.98 06/05/2024 Food and Beverage Undisputed 01/23/2026 1116169442 CMS
GlaxoSmithKline, LLC. $23.54 07/17/2024 Food and Beverage Undisputed 01/23/2026 1116418766 CMS
GlaxoSmithKline, LLC. $32.29 12/03/2024 Food and Beverage Undisputed 01/23/2026 1116287382 CMS
Grifols USA, LLC $22.51 09/13/2024 Food and Beverage Undisputed 01/23/2026 1124748277 CMS
kaleo, Inc. $24.38 07/17/2024 Food and Beverage Undisputed 01/23/2026 1126630118 CMS
Krystal Biotech Inc $29.94 08/15/2024 Food and Beverage Undisputed 01/23/2026 1084810520 CMS
Novartis Pharmaceuticals Corporation $19.08 04/17/2024 Food and Beverage Undisputed 01/23/2026 1086943547 CMS
Novartis Pharmaceuticals Corporation $17.11 06/13/2024 Food and Beverage Undisputed 01/23/2026 1086943549 CMS
Novartis Pharmaceuticals Corporation $19.59 08/07/2024 Food and Beverage Undisputed 01/23/2026 1086943557 CMS
Novartis Pharmaceuticals Corporation $13.45 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086943551 CMS
Octapharma USA, Inc. $17.80 03/06/2024 Food and Beverage Undisputed 01/23/2026 1142315607 CMS
Octapharma USA, Inc. $22.88 04/24/2024 Food and Beverage Undisputed 01/23/2026 1142315609 CMS
Octapharma USA, Inc. $23.26 11/13/2024 Food and Beverage Undisputed 01/23/2026 1142315611 CMS
PFIZER INC. $33.77 02/22/2024 Food and Beverage Undisputed 01/23/2026 1131306480 CMS
PFIZER INC. $37.04 08/08/2024 Food and Beverage Undisputed 01/23/2026 1131874829 CMS
Regeneron Healthcare Solutions, Inc. $30.78 03/28/2024 Food and Beverage Undisputed 01/23/2026 1114074845 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.09 06/19/2024 Food and Beverage Undisputed 01/23/2026 1137584224 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.